United Therapeutics Corp.
(NASDAQ : UTHR)

( )
UTHR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. -2.58%24.9214.1%$146.63m
ICLRICON plc -0.44%255.922.8%$144.79m
HZNPHorizon Therapeutics Plc -1.67%86.575.4%$106.97m
CTLTCatalent, Inc. -0.48%102.072.0%$104.75m
BHCBausch Health Cos., Inc. -2.58%24.920.0%$102.00m
SAVACassava Sciences, Inc. -9.13%37.410.0%$90.10m
JAZZJazz Pharmaceuticals Plc -1.07%139.132.1%$86.34m
UTHRUnited Therapeutics Corp. -2.49%199.9713.9%$78.20m
ZGNXZogenix, Inc. 0.31%26.007.5%$67.37m
ARGXargenx SE 0.99%281.480.0%$50.38m
PRGOPerrigo Co. Plc -0.18%39.736.9%$48.99m
PCRXPacira Biosciences, Inc. -0.41%64.009.8%$28.57m
BRBRBellRing Brands, Inc. -2.02%24.250.0%$26.01m
IRWDIronwood Pharmaceuticals, Inc. -2.41%10.929.5%$22.19m
CORTCorcept Therapeutics, Inc. -2.35%17.475.5%$18.09m

Company Profile

United Therapeutics Corp. operates as a biotechnology company which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. The firm markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. It is involved in the development of novel pharmaceutical therapies and technologies that expand the availability of transplantable organs. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.